Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Great experience with this product
For the full picture of what this peptide can and cannot do, the complete AOD 9604 guide covers the evidence in detail, including the specific trial data
Quick Facts HQ: Cambridge, United Kingdom FY2024 Revenue: USD 54.1B FY2024 (+18% YoY)
For the bigger picture, read how peptide therapy is supervised at Perfect B in Doral and where a specific peptide fits within a complete treatment plan
Primary Target NNMT Enzyme The molecular target of 5-Amino 1MQ is the cytosolic enzyme nicotinamide N-methyltransferase (NNMT), a metabolic regulator highly expressed in adipose tissue, liver, and skeletal muscle particularly in obesity and type 2 diabetes
